JP Clinical Consultancy Ltd 15426199 false 2024-01-19 2025-01-31 2025-01-31 The principal activity of the company is Other business support service activities not elsewhere classified Digita Accounts Production Advanced 6.30.9574.0 true 15426199 2024-01-19 2025-01-31 15426199 2025-01-31 15426199 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 15426199 bus:Micro-entities 2024-01-19 2025-01-31 15426199 bus:AuditExemptWithAccountantsReport 2024-01-19 2025-01-31 15426199 bus:FullAccounts 2024-01-19 2025-01-31 15426199 bus:SmallCompaniesRegimeForAccounts 2024-01-19 2025-01-31 15426199 bus:RegisteredOffice 2024-01-19 2025-01-31 15426199 bus:Director1 2024-01-19 2025-01-31 15426199 bus:PrivateLimitedCompanyLtd 2024-01-19 2025-01-31 15426199 countries:EnglandWales 2024-01-19 2025-01-31 iso4217:GBP xbrli:pure

Registration number: 15426199

JP Clinical Consultancy Ltd
Unaudited Filleted Financial Statements
for the Period from 19 January 2024 to 31 January 2025

JP Clinical Consultancy Ltd

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 2

JP Clinical Consultancy Ltd

Company Information

Director | Janoo Patel

Registered office | 36 Raywell Road Leicestershire Leicester LE5 1WX

JP Clinical Consultancy Ltd

(Registration number: 15426199)
Balance Sheet as at 31 January 2025

| 2025 £
Current assets | 6,918
Prepayments and accrued income | 61
Creditors: Amounts falling due within one year | (5,452)
Total assets less current liabilities | 1,527
Accruals and deferred income | (900)
| 627
Capital and reserves | 627

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
36 Raywell Road
Leicestershire
Leicester
LE5 1WX

These financial statements were authorised for issue by the director on 3 October 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2 | Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

For the financial period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

JP Clinical Consultancy Ltd

(Registration number: 15426199)
Balance Sheet as at 31 January 2025 (continued)

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 3 October 2025

......................................... Janoo Patel Director